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Global expansion of Mycobacterium tuberculosis lineage 
4 shaped by colonial migration and local adaptation
Ola B. Brynildsrud1, Caitlin S. Pepperell2,3, Philip Suffys4, Louis Grandjean5, Johana Monteserin6,7, 
Nadia Debech1, Jon Bohlin1, Kristian Alfsnes1, John O.-H. Pettersson1,8,9,10, Ingerid Kirkeleite1, 
Fatima Fandinho11, Marcia Aparecida da Silva11, Joao Perdigao12, Isabel Portugal12, 
Miguel Viveiros13, Taane Clark14,15, Maxine Caws16,17, Sarah Dunstan18,  
Phan Vuong Khac Thai19, Beatriz Lopez6, Viviana Ritacco6,7, Andrew Kitchen20,  
Tyler S. Brown21, Dick van Soolingen22, Mary B. O’Neill3,23*, Kathryn E. Holt14,24,  
Edward J. Feil25, Barun Mathema26, Francois Balloux27, Vegard Eldholm1†
On the basis of population genomic and phylogeographic analyses of 1669 Mycobacterium tuberculosis lineage 
4 (L4) genomes, we find that dispersal of L4 has been completely dominated by historical migrations out of Europe. 
We demonstrate an intimate temporal relationship between European colonial expansion into Africa and the 
Americas and the spread of L4 tuberculosis (TB). Markedly, in the age of antibiotics, mutations conferring anti-
microbial resistance overwhelmingly emerged locally (at the level of nations), with minimal cross-border trans-
mission of resistance. The latter finding was found to reflect the relatively recent emergence of these mutations, 
as a similar degree of local restriction was observed for susceptible variants emerging on comparable time scales. 
The restricted international transmission of drug-resistant TB suggests that containment efforts at the level of 
individual countries could be successful.
INTRODUCTION
Tuberculosis (TB) takes more lives than any other infectious disease. 
Global TB burden has declined slowly over the past decade, but the 
rise of antimicrobial resistance (AMR) constitutes a significant 
obstacle to TB control in the absence of an effective vaccine. In 
recent years, a number of attempts have been made to reconstruct 
the evolutionary history of Mycobacterium tuberculosis (M.tb) and 
its association with humans. One genome-based study hypothe-
sized that M.tb spread out of Africa together with early humans (1), 
whereas a later study, using ancient DNA samples for temporal 
calibration, suggested a far younger most recent common ancestor 
(MRCA) of extant M.tb 4000 to 6000 years ago (2). Among seven 
recognized M.tb lineages, lineage 4 (L4) is the most widely dis-
persed, affecting humans across the world. Here, relying on a 
collection of 1669 L4 genomes, including hundreds of novel ge-
nomes from the Americas, we set out to reconstruct the migration 
history of L4 and assess the impact of migration on the spread of 
AMR. We find that repeated sourcing from Europe has been the 
main driving force for the global expansion of L4, with intense 
dispersal to Africa and the Americas concomitant with European 
colonizing efforts ca. 1600–1900 CE. We also find that the rise of 
multidrug-resistant TB (MDR-TB) in recent decades is over-
whelmingly a local phenomenon, in the sense that resistant clones 
have emerged repeatedly in a wide variety of locations, while migra-
tion of resistant strains seems to have played a marginal role in 
shaping the observed L4 AMR landscape.
RESULTS AND DISCUSSION
Global diversity of L4
In total, 1669 genomes representing clinical M.tb isolates from 15 
countries were included in the study (Fig. 1). After down-sampling 
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of densely sampled outbreaks (see Materials and Methods), 1205 
isolates remained. To get an overview of global patterns of genomic 
diversity and strain distribution, we assigned each genome to a 
sublineage based on the Coll scheme (3) and mapped the sublineage 
annotations on the temporal phylogeny (Fig. 1). In general, sub-
lineages were found to be widely dispersed, but clear patterns of 
geographic structure are discernible, as noted by Stucki et al. (4): 
L4.5 was restricted to Southeast Asia (Vietnam), whereas L4.3 (also 
termed LAM) was underrepresented in the country (Fig. 2). We 
also observed early, distinct splits within sublineages 4.2 and 4.4; 
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Fig. 1. Sampling overview and phylogeography of the global L4 dataset. In the map, sampled countries are colored by continent, and sample sizes are indicated. In 
the temporal phylogeny, branches are colored to match the most likely geographic location inferred using BASTA. MDR clusters identified in the dataset are highlighted 
with black background shading. A large black asterisk highlights the branch leading to the DS6Quebec clade that was used to assess robustness of dating analyses, where-
as yellow dots indicate independent introductions of the KZN ancestor to South Africa and South America (see main text for details).
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L4.2 consists of a Vietnamese cluster nested within the otherwise 
strictly European sublineage, whereas an early branching event 
separates L4.4 into two clades, one exclusively detected in Vietnam 
and the other global in its distribution.
To assess the overall L4 diversity as a function of geography, 
we investigated the distributions of pairwise single-nucleotide poly-
morphism (SNP) differences in countries where sampling was 
deemed to be sufficiently dense and representative (Fig. 2). Russia, 
the Netherlands, and Vietnam were characterized by the highest 
diversity in circulating L4 strains, both in terms of median pairwise 
distance and Simpson’s diversity (which also takes sublineage 
distribution into account). Comparing the patterns of diversity in 
Malawi and Vietnam, representing large collections from Karonga 
district and Ho Chi Minh City, respectively (5, 6), the SNP distance 
distributions indicate more ongoing transmission of L4 in Malawi 
(where pronounced peaks in the lower tail of the pairwise distance 
distribution is visible) relative to Vietnam.
Phylogeographic inference
Next, we performed analyses to formally assess the phylogeo-
graphic history of L4. We used both discrete trait analyses (DTA) 
(7) and Bayesian-structured coalescent approximation (BASTA) 
(8). For both analyses, a temporal phylogeny inferred with Bayesian 
evolutionary analysis sampling trees (BEAST) v1.8.4 (9) was used as 
an input tree, and a sampling location was used to assign samples to 
one of five regions: Europe, Africa, Southeast Asia, South America, 
and North America [Russian isolates were assigned to Europe, since 
all isolates were sampled West of Ural, in accordance with United 
Nation’s (UN) geoschemes]. The L4 MRCA was estimated to have 
existed around 1096 CE [95% highest posterior density (HPD), 955 
to 1231] (see the Supplementary Materials). Applying DTA, the geo-
graphic location of the MRCA was estimated to be Europe with high 
confidence (posterior probability = 0.92).
BASTA initially placed the root location in South America, 
which in light of the estimated age of L4 is highly unlikely, and also 
necessitated migration events to the Old World in the centuries 
immediately preceding the Columbian discovery of the Americas. 
We thus performed individual analyses with the root location 
forced to be any of the three Old World continents to which our 
samples belonged. In these analyses, a European root location was 
overwhelmingly favored (see Materials and Methods). The result-
ing migration matrices estimated by DTA and BASTA were largely 
concordant (fig. S5), both methods inferring Europe as playing a 
pivotal role in the global dispersal of L4. The central role of Europe 
in the global expansion of L4 was most pronounced in the BASTA 
inferences, where out-of-Europe migration was found to be almost 
singlehandedly responsible for the current geographic range of L4 
(Fig. 3A). However, “Europe” should not be interpreted in the strict 
sense and probably captures interactions in the Middle ages with 
western Asia and North Africa as well. Thus, our study does not 
contradict an origin around the Mediterranean, as suggested in a 
recent study (10).
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Fig. 2. Within-country diversity as assessed by mean pairwise SNP distances (only including well-sampled countries). Vertical dashed lines indicate median values. 
Embedded pie charts summarize sublineage distribution within each country. The Simpsons diversity index (1-D) was calculated at the level of subspecies and the esti-
mate indicated in the top of each county panel (where higher values correspond to increased diversity).
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Patterns of L4 migration through time
To investigate the migration history of L4 in a temporal context, 
we analyzed the inferred load and direction of migration over time 
(see Materials and Methods). As it was clear that out-of-Europe 
migrations were the overwhelming driver of global L4 range expan-
sion (Fig. 3A), we illustrate migration from Europe to the other 
continents through time in Fig. 3B. In parallel, we analyzed migra-
tion events within the receiving continents to get a picture of the 
relative importance of import versus intracontinental transmission 
(Fig. 3C).
Our phylogeographic analyses suggest that the first waves of L4 
migration out of Europe were in an eastward direction, with the 
first migration to Southeast Asia (represented by Vietnam) esti-
mated to the beginning of the 13th century. Here, local populations 
were quickly established, and internal transmission became domi-
nant by the late 16th century (Fig. 3C). These observations fit well 
with the observed population structure of the Vietnamese isolates 
(Fig. 1) and the high diversity observed within the country (Fig. 2). 
Present-day Vietnam was part of a large French colony termed 
French Indochina from the late 19th century onward. France was 
not among the sampled countries in the current study, but focusing 
on the Netherlands, the most proximal, sampled country, we iden-
tified a number of nodes with Vietnamese and Dutch descendants 
only, the first dated to 356 to 426 years before present (95% HPD), 
followed by six nodes with 95% HPDs from 114 to 269 years ago. 
These date ranges fit well with known French-Vietnamese inter-
actions, starting with the arrival of the missionary Alexandre de 
Rhodes in the 1627 (11) followed by French military expansion 
from the mid 19th century and the formation of French Indochina 
in 1887.
The next waves of migration were directed toward Africa, 
with the earliest introduction among the sampled countries in-
ferred in the present-day Republic of Congo (Congo-Brazzaville) 
in the 15th century and subsequent introductions to South Africa, 
Uganda, and Malawi (Southern and Eastern Africa) from the late 
17th century. The early introduction in Congo is likely a result 
of the relatively proximity of Congo-Brazzaville to the West African 
territories, which were first to interact with European explorers. 
In contrast to what we observed for Southeast Asia, repeated sourc-
ing from Europe seems to have been more important than local 
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Fig. 3. L4 migration. (A) Heatmap summarizing the overall migration load between continents as inferred in BASTA. (B) Temporal overview of L4 migration out of Europe. 
The establishment of strains of interest discussed in the text is highlighted. As the exact timing of the first American migrations was uncertain, the mean of the first three 
inferred migration events to each of the two subcontinents is reported as an approximation of the earliest migration events to the Americas. (C) Out-of-Europe migration 
to Southeast Asia, Africa, and South America over time. The plots also show within-continent migration/transmission in the receiving continents to illustrate the relative 
importance of repeated L4 import on continental L4 load over time. SE, southeast.
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transmission until the 19th century (Fig. 3C). These findings closely 
mirror the European colonial history in Africa south of the Sahara, 
with early Portuguese forts and trading posts established on the 
Gold Coast (present-day Ghana) in 1482, followed by an ever in-
creasing European presence and influence in African coastal re-
gions over the next centuries. Last, this culminated in an all-out 
land grab termed the “scramble for Africa” in the late 19th century, 
placing vast portions of the African continent under European 
control in the form of colonies. Our findings thus suggest an inti-
mate relationship between European colonial expansion and 
the spread of L4 TB on the African continent. The main form of 
internal African migration in this time period was connected to the 
expansion of the Zulu Empire under Shaka (1816–1828), which 
forced fleeing tribes to migrate northward and eastward. This appears 
to have been less important in the spread of L4, but internal nodes 
with descendants in Congo, Uganda, and Malawi dated to the 18th 
to 20th century point to secondary transmission routes through 
internal African migration.
The three earliest migration events to the Americas were in-
ferred to have occurred between 1466 and 1593 to South America 
and between 1566 and 1658 to North America. These migration 
events occurred along long branches of the phylogeny, so the exact 
timing cannot be established. The estimates do however suggest 
that Europeans brought TB to South America relatively soon after 
the arrival of Europeans on the continent in 1492. An abrupt in-
crease in the flow of L4 into South America is seen from the turn of 
the 17th century (Fig. 3). Bone pathology and lesions identified in 
human remains suggest that TB in the Americas might have pre-
dated European contact (12), but convincing molecular evidence is 
limited to the identification of Mycobacterium pinnepedii infection 
(a M.tb complex member generally restricted to seals and sea lions) 
in skeletal samples from a Peruvian coastal settlement (2). As the 
original human colonization of the Americas predates the likely age 
of the M.tb MRCA (2) by a large margin, the most parsimonious 
interpretation is that, while animal strains were in circulation in 
some Native American human populations, M.tb sensu stricto was 
introduced to the Americas by European colonists and followed by 
continued influx of L4 with subsequent waves of European mi-
grants. The near-complete dominance of L4 in South America (13) 
also supports this notion.
Despite the massive and relentless import of TB, we find that the 
establishment of detectable local transmission was delayed in South 
America relative to Africa and Southeast Asia (Fig. 3), which might 
reflect the massive decline of native populations following European 
contact. Infectious diseases caused severe die-offs of native popula-
tions following the arrival of Europeans (14). The toll taken by 
infectious disease epidemics in Native Americans is ascribed to their 
vulnerability to a number of pathogens introduced by Europeans 
and was likely exacerbated by widespread societal collapse and 
famines. The near-wholesale replacement of Native Americans 
with Europeans and African slaves in many regions (14) might 
explain the delayed imprints of local TB transmission in our phylo-
geographic analyses. A figure including migration over time to both 
North (relatively sparsely sampled after down-sampling of out-
breaks) and South America is included in fig. S6.
The phylogeographic analyses also allowed us to shed light on 
the history of specific strains of interest. In South Africa, the KZN 
strain is responsible for a devastating epidemic of extensively 
drug-resistant TB (XDR-TB) (15, 16). We find that the ancestor of 
the KZN strain was dispersed with Europeans to South Africa about 
130 years ago (Fig. 3B). In the same period, about 100 to 150 years 
ago, there were independent introductions of a closely related strain 
from Europe to Latin America, providing context to the observation 
by Lanzas et al. (17) that strains closely related to the KZN strain are 
driving an MDR-TB outbreak in Panama.
Another interesting finding concerns the RdRio clade, originally 
identified as a major cause of TB in Brazil (18) but later identified at 
moderate to high frequencies also in Portugal, the United States, and 
beyond (19, 20). Our results suggest that the RdRio clade originated 
in Europe about 350 years ago, followed by multiple introductions 
to Africa and the Americas from around 250 years ago. To investi-
gate this clade in more detail, we extracted the RdRio subtree from 
the full L4 phylogeny and performed an independent phylogeo-
graphic analysis. This analysis indicated Iberia as a likely origin of 
RdRio, followed by early expansions to Atlantic South America, 
Peru, and Southeast Africa (fig. S7).
Furthermore, we find that the ancestors of two major MDR 
outbreak strains in Argentina, M (21) and Ra (22), were both intro-
duced to South America approximately 200 years ago. The L4 
DS6Quebec clade is common among Aboriginal populations in 
Ontario, Saskatchewan, and Alberta, as well as French Canadians 
in Quebec. As substantial contact between these populations was 
limited to the period of 1710 to 1870 (23), this provides a useful 
interval against which to test our temporal inferences. Our analyses 
places the MRCA of DS6Quebec in Canada in 1788 [95% HPD, 1739 
to 1827] well within this interval. The inferred timing of L4 migra-
tion to Africa and the Americas fits remarkably well with the known 
history of European colonization of the continents. A summary 
of the direction, intensity, and timing of L4 migration is included in 
Fig. 3.
Local adaptation and AMR
For clonal, nonrecombining organisms such as M.tb, the iden-
tification of homoplasic mutations is a powerful way to iden-
tify targets of selection (24). We identified a total of 733 mutations 
that had emerged more than once in the L4 dataset. As expected, 
the top-scoring genes included a number of known AMR genes 
(dataset S2). We also identified a handful of promoter and non-
synonymous gene mutations (codons 3 and 253) in the lactate 
dehydrogenase gene lldD2 that had evolved independently > 100 
times. A recent study demonstrated that lldD2 is important for 
M.tb replication within human macrophages by enabling the 
bacillus to use lactate as a carbon source (25). A screen for positive 
selection in a smaller dataset covering M.tb lineages 1 to 6 (26) 
found that the codon 3 mutation had emerged independently in 
lineages 1, 2, and 4, whereas the codon 253 mutation had emerged 
repeatedly in L4 and was present in all but a single L2 isolate. 
In L4, we find that lldD2 mutations started emerging well before 
the age of antibiotics (fig. S9) and have emerged across all con-
tinents (dataset S3), suggesting parallel local adaptation, most 
likely to broad changes in host ecology. Last, we assessed the 
transmissibility of clades with and without lldD2 mutations, 
both in terms of number of descendants per node age and in 
terms of transmission across country borders (see supplemen-
tary text). These analyses suggested that there were indeed dif-
ferences between the groups and that strains harboring lldD2 
promoter mutations carry a significant benefit in terms of 
transmissibility.
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The most serious challenge to TB control efforts is the rise of 
AMR, which is threatening to reverse the moderate decrease in TB 
burden obtained over the last decade (27). To investigate the role of 
migration in the spread of AMR, we mapped the time and location 
of resistance emergence by mapping known resistance mutations 
on the temporal phylogeny. For clarity, we only included genes 
relevant for the multi- and extensive drug resistance definitions 
[MDR-TB, resistance to isoniazid (INH) and rifampicin (RIF); 
XDR-TB, MDR-TB with additional resistance to fluoroquinolones 
(FLQ) and one of the injectable drugs kanamycin, amikacin, or 
capreomycin]. As the major mutations responsible for kanamycin, 
amikacin, and capreomycin resistance are largely overlapping, we 
refer to this group as KAN resistance mutations. The stacked bar 
chart summarizing the inferred timing of individual resistance 
emergence events (Fig. 4, top) indicates a gradual increase in AMR 
emergence rate from the 1960s until the late 1990s, after which a 
plateau is reached. In line with an earlier global study of AMR in 
M.tb (28), we find that MDR-TB has emerged repeatedly and 
independently across geographic regions (Fig. 1).
When extracting the geographic location of isolates descending 
from resistance nodes (i.e., inherited resistance), we did not identify 
a single instance of a resistant strain crossing country borders. To 
understand the underlying cause of this observation, we first inves-
tigated whether this reflected a decrease in transmission fitness of 
resistant strains (see Materials and Methods). This analysis did 
not indicate any decrease in the transmissibility of resistant strains 
relative to their susceptible counterparts (Fig. 4, bottom). We thus 
hypothesized that the failure of resistant strains to cross country 
borders in our global dataset might simply reflect the young age 
of these strains. Cross-country and cross-continental migration 
events as a function of node age and the predicted phenotypic resist-
ance of the strain occupying the node were thus quantified. From 
Fig. 4 (middle), it is clear that cross-border migration was exceed-
ingly rare among descendants of nodes young enough to be resist-
ance nodes, irrespective of susceptibility profile. Only a single node 
emerging within the age of antibiotics (post 1945) was found to 
have descendants that had crossed country borders in our dataset. 
We thus conclude that the young age of resistance nodes, rather 
than decreased transmission fitness, explains the lack of observed 
migration of these strains.
Concluding remarks
As a result of the clonal mode of M.tb replication (29), efficient 
adaptive evolution across populations requires the parallel evolu-
tion of beneficial mutations. This is indeed the pattern we observe 
both for adaptive mutations in the lactate metabolism gene lldD2 
and, importantly, the emergence of multidrug resistance across 
the L4 phylogeny (Fig. 1). AMR emergence within L4 TB reflects 
local adaptations to near-identical treatment schemes across di-
verse geographic contexts. There is no doubt that resistant M.tb 
strains can cross country borders and has been observed, e.g., in 
the case of resistant L2 isolates imported from Eastern to Western 
Europe (30), but we demonstrate that migration has played a negli-
gible role in shaping global AMR patterns in L4. The geographic 
restriction of resistant strains is indeed striking and suggests that 
the challenge of AMR can still be tackled efficiently at the level 
of individual nations. If, however, we fail to act swiftly using the 
best informed interventions available, then this picture might change 
rapidly.
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Fig. 4. Transmission of resistance. (Top) Independent emergence of AMR over time 
based on the age of nodes where resistance mutations were inferred to have emerged. 
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MATERIALS AND METHODS
Sample collection
To aid population genomic and phylogeographic inferences, we 
aimed to include large and representative sample collections cover-
ing the widest obtainable temporal and geographic range for the 
study. We included L4 genomes from recently published studies from 
Argentina (21), Canada (31), Congo-Brazzaville (32), Malawi (33), 
Netherlands (34), Portugal (35), Russia (30), South Africa (15), 
Uganda (28), United Kingdom (30), United States (36), and Vietnam 
(6). To further improve temporal structure and resolution, we also 
included three genomes isolated from 18th century Hungarian mum-
mies (37) and genomes from Denmark sampled in the 1960s and 
1990s (38). In addition to published genomes, we included 627 
previously unpublished genomes from the Americas (Brazil, Peru, 
Argentina, United States, and Canada). Sequencing libraries were 
prepared as described previously (39) and sequenced on an Illumina 
platform. Inclusion criteria for individual genomes were as follows: 
(i) The genome was annotated with a minimum of metadata (sam-
pling year and country of origin), or this information could be 
obtained from the published articles or by correspondence with 
personnel involved in the sequencing efforts. (ii) The genome had 
to be L4, as verified by the program TB profiler (40). Genomes that 
were determined to be of mixed origin were also excluded. (iii) If a 
genome was determined to be a duplicate of an already included iso-
late, then it was not included. (iv) All of the following quality control 
criteria had to be met: (iv-a) When mapping reads against a H37Rv 
reference genome, a minimum genome coverage of 90% had to be 
reached. (iv-b) The average read depth across the reference had to 
exceed 20. We allowed sequence data from different Illumina plat-
forms and with different read lengths. A total of 1669 genomes passed 
all inclusion criteria (dataset S1).
Samples from Argentina and from a study of an Inuit community 
in Quebec, Canada (31) were mainly from outbreaks and thus har-
bored limited within-population diversity. To control for the effect 
of densely sampled genomes on certain analyses, we additionally 
created a down-sampled genome collection, where we allowed only 
five isolates from each of the Argentinian outbreaks (M and Ra) and 
10 from the outbreak in Quebec. These genomes were randomly 
sampled from the full collection by a random number generator. In 
total, the down-sampled isolate contained 1207 isolates, including 
the H37Rv reference and an L3 outgroup isolate.
Variant calling
The snippy pipeline v3.1 (https://github.com/tseemann/snippy) was 
used for variant calling. Briefly, this entailed mapping reads against 
H37Rv with the BWA mem algorithm (v.0.7.15-r1110) and mark-
ing split hits as secondary and then calling variants with SAMtools 
v1.3 and including only reads with a mapping quality of 60 or high-
er. Variants were then filtered further using FreeBayes (v1.0.2) with 
a ploidy of 1 and options to exclude (i) alleles if a supporting base 
quality is less than 20 or the coverage less than 10, (ii) alignments 
if the mapping quality is less than 60, and (iii) alleles if the frac-
tion of reads in support of a SNP is not at least 90%. The binomial 
priors about observation expectations were turned off. The program 
snpEff v4.1l was then used to annotate SNPs, turning off downstream, 
upstream, intergenic, and 5′ untranslated region (5′UTR) and 3′UTR 
changes. A whole-genome alignment of all genomes was then built 
using snippy core, with a minimum coverage depth of 10 to consider 
a region part of the core.
The genome sequences from the Hungarian mummies were 
resolved in a different manner: Sequence read archives from study 
PRJEB7454 (37) were mapped to H37Rv (41). A minimum read 
length of 35 bp (base pairs) and a minimum mapping quality of 30 
were imposed. Pilon was run with the following parameters: – vari-
ant – mindepth (10) – minmq (30) – minqual (30), and the num-
ber of reads found supporting each allele across all variant sites 
were manually inspected. Three genotypes were inferred from two 
high- coverage sequencing runs [ERR651000 (individual 68) and 
ERR651004 (individual 92)]. Genotypes were distinguished on the 
basis of allele frequencies. For individual 68, genotype 1 was de-
duced by alleles found between 55 and 65% and genotype 2 by al-
leles found between 35 and 45%. Variants at frequencies of ≥95% 
were considered fixed between the mixed infecting strains. Vari-
ants segregating at other frequencies were treated as ambiguous/
missing data. For individual 92, we also found evidence indicative 
of a mixed infection; however, we only felt confident with the most 
called genotype, which comprised >90% of reads. All variants at 
≥95% were called. All other sequencing runs from the project were 
of low coverage and excluded from the analyses.
We then used an in-house python script (available at https://
github.com/admiralenola/globall4scripts) to exclude, from the 
alignment, SNPs matching any of the following criteria: (i) lo-
cated in a known repetitive region (e.g., PE/PPE genes, annota-
tion file available at github repository), (ii) the proportion of 
ambiguous calls at the locus exceeded 1%, and (iii) the position 
was no longer polymorphic after pruning of outbreak isolates 
(only applied to the down- sampled dataset). The final alignment 
of SNPs consisted of 22,912 sites, with 9313 of these being parsi-
mony informative.
Initial phylogenetic analysis
The program ModelFinder (42) as implemented in IQ-TREE was 
used to infer the optimal substitution model for our genome align-
ment. A maximum-likelihood phylogenetic tree was then built 
using the program IQ-TREE v1.4.3 (43), applying the generalized time- 
reversible (GTR) model with four gamma categories for rate varia-
tion, ascertainment bias on, and 1000 ultrafast bootstrap replicates (44). 
The L3 isolate SRR1188186 (Quebec, Canada) was used as an outgroup.
AMR gene mutations
Many M.tb AMR mutations are known, but the contribution to 
the resistance phenotype and penetrance remains unclear for a 
substantial fraction of variants. We therefore included only high- 
likelihood AMR mutations relevant for the MDR and XDR defini-
tions. All loci were selected a priori for their perceived relevance 
and strength of association to AMR. For INH, we included the 
katG S315T mutation and any nonsense or frameshift mutations 
in the gene plus the classical −15 and −8 inhA promoter muta-
tions. For RIF, we included all nonsynonymous mutations in the 
resistance-determining region (amino acids 426 to 450) of rpoB. 
For kanamycin/amikacin/capreomycin, we included eis promoter 
mutations in positions −14, −12, and −10 (35, 45), as well as 
mutation in position 1401 of rrs. For FLQ, we restricted the analysis 
to a manually curated collection of high-likelihood mutations, 
namely, gyrB mutations leading to amino acid substitution at 
positions 461, 499 to 501, and 642, as well as gyrA mutations 
resulting in amino acid substitutions at positions 88 to 94 and 
288 (46, 47).
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Resistance-associated loci were extracted from the whole-genome 
alignment using EMBOSS v6.6.0.0 (48) using their H37Rv coordinates. 
The loci were translated to protein, and sequences were sorted by 
alleles. Mutations were manually annotated on the phylogenetic tree 
using simple parsimony (e.g., an internal node was inferred to have 
allele A if all descendent nodes had allele A.). The figure was drawn 
using iTOL (49).
Population genomic inferences
Gene-wise estimates of nucleotide diversity (), Watterson’s theta (), 
and Tajima’s D were computed for each gene by parsing the whole- 
genome alignment into genes using EMBOSS (48) and using the py-
thon package EggLib (50) on individual gene alignments. Fst values 
were also calculated using EggLib, specifying groups by (i) country 
and (ii) sublineage as identified by the TB profiler. Within each 
country, we calculated genomic pairwise Hamming distances using 
the program snp-dists (https://github.com/tseemann/ snp-dists).
For each gene, we additionally calculated the number of homo-
plasies and number of homoplasic sites using a Fitch downpass al-
gorithm, as implemented in Dendropy (51). Gene-wise parsimony 
scores were calculated by identifying homoplasic mutations in each 
gene and summing the Fitch parsimony scores (i.e., the minimum 
number of independent emergences of each mutation). To investi-
gate potential alterations of fitness induced by the various muta-
tions in and immediately upstream of the lldD2 gene, we devised a 
metric for transmissibility associated with each mutation akin to 
(6). First, homoplasies in this gene were categorized as being in the 
promotor region, in codons 3 and 253. All homoplasy emergences 
were mapped to the respective branch in the full phylogenetic time 
tree. For each homoplasy, we recorded the subtree’s number of 
descendents and number of deme transitions. The reasoning behind 
this was that ancestors with homoplasic mutations increasing trans-
missibility should have more descendents and more deme transi-
tions per time than ancestors without these mutations. For this 
latter control group, we randomly extracted subtrees of comparable 
height distribution to those subtrees with promoter/codon 3/codon 
253 mutations, and we labeled this control group as “none” (that is, 
no homoplasic mutations in lldD2). Figure S2 shows a linear model 
between subtree height and the number of sampled descendents by 
each mutation category. To test whether these categories have 
different slopes, we used an analysis of covariance (ANCOVA) 
procedure. First, a simple null model, where the number of descend-
ents are dependent on subtree height but not on the mutation 
category (including the none group), was set up. An alternative 
model is that the relationship between the subtree height and the 
number of descendents varies between these four different muta-
tion categories. For each of these models, we weighted the number 
of deme transitions as (number of deme transmissions)2 + 1, i.e., no 
transitions got a weight of 1, one transition got a weight of 2, 
and two transitions got a weight of 5. The ANCOVA rejected the 
null model, showing significant preference for the per-group model 
(F test, P = 0.038). Analysis of individual height-group interaction 
terms showed that the coefficient for promotor mutations was 
significantly different from zero, indicating a positive association 
between lldD2 promotor mutations and transmissibility. Note that, 
if the weighting by deme transitions is removed, the ANCOVA no 
longer significantly prefers the alternative model (F test, P = 0.114), 
and there is no evidence for homoplasy group interaction with height 
and number of descendants.
Phylogenetic and phylogeographic inference
To estimate substitution rates by means of sampling date calibrated 
Bayesian evolutionary analyses (52), we down-sampled the collec-
tion to a manageable size by including a maximum of 20 randomly 
chosen isolates from each country. This resulted in a sample collec-
tion of 269 genomes. Three ancient M.tb genomes from 18th century 
Hungarian mummies (37) and five Danish isolates from the 1960s 
(38) were included to provide temporal structure to the data.
A total of 7994 variable sites remained after selecting the 269 
genomes. A preliminary check using TempEst (53) confirmed a moder-
ate but highly significant temporal signal in the data (fig. S4), which 
was also confirmed by tip randomization (see below). A GTR sub-
stitution model was chosen on the basis of model testing, as described 
above. On the basis of marginal-likelihood estimation (MLE), an 
exponential demographic model was found to best fit the data [tested 
against the constant population size and Gaussian Markov Random 
Fields (GMRF) skyride models (54)]. Also based on MLE, an uncor-
related relaxed clock was favored over a strict clock model. Three inde-
pendent BEAST Markov Chain Monte Carlo (MCMC) chains were run, 
and convergence to a stationary posterior distribution was confirmed 
both within and between chains. These analyses resulted in an estimated 
substitution rate of 4.84 × 10−8 (95% HPD, 4.16 × 10−8 to 5.44 × 10−8) 
substitutions per site per year and an estimated time of the MRCA 
in 1096 CE (95% HPD, 955 to 1231). To assess the robustness of the 
temporal inference, we performed 10 additional runs after random-
ization of the sampling dates (55). None of the randomized runs had 
rate estimates overlapping with the inference using real sampling dates 
(fig. S3), supporting the robustness of the original inference.
We then ran a larger dataset (1207 genomes, after retaining a 
maximum of five representatives from each of three densely sampled 
outbreaks from Argentina and 10 from Quebec, Canada) in BEAST 
v1.8.4 (56) with a fixed substitution rate as estimated above. The 
MRCA of this tree was inferred to have existed in the year 1157 
(HPD intervals not reported due to our application of a fixed rate in 
this analysis). The overall accuracy of the dating inferences in BEAST 
was further supported by independent analyses applying Least Squares 
Dating (LSD) v0.3 (57), resulting in an estimated time to MRCA in 
1195 CE (95% HPD, 1061 to 1270) for the 1207 genome dataset. The 
tree generated for 1207 genomes in BEAST v1.8.4 was used as an input 
tree for phylogeographic analyses using both the BASTA module in 
BEAST2 and simple DTA as implemented in BEAST v1.8.4 (9).
To reduce computational complexity and increase post-analysis 
interpretability, we collapsed the country of origin information into 
five distinct UN regions: North America (United States and Canada), 
South America (Brazil, Argentina, and Peru), Africa (Democratic 
Republic of the Congo, Malawi, South Africa, and Uganda), Europe 
(Denmark, the Netherlands, Hungary, Portugal, Russia, and United 
Kingdom), and Southeast Asia (Vietnam).
In the discrete trait model (7), we used a GTR model, restricted the 
clock rate to 4.84 × 10−8, and set the starting tree as specified above. 
The prior population size was set as constant. A symmetric deme sub-
stitution model was used, and we turned Bayesian stochastic search 
variable selection on. Ancestral states were reconstructed at all nodes. 
Other priors were left at default values. The chain was run for 
10,000,000 generations with logging every 10,000th iteration, and three 
of these runs were combined to create the final posterior sample of 
trees and parameters. We verified chain convergence and good mix-
ing and an effective sample size (ESS) > 200 for all parameters using 
Tracer (http://tree.bio.ed.ac.uk/software/tracer/). A maximum clade 
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credibility (MCC) tree was created using TreeAnnotator (http://
beast.community/treeannotator), with 20% of the chain discarded 
as burn in. The resulting tree displayed a European root with 92% 
posterior probability.
A separate phylogeographic reconstruction of the L4.3 RdRio 
family was also performed. This was completed by manually ex-
tracting the RdRio subtree from the full time tree and then setting 
up a new DTA run consisting of these 243 isolates alone. For this 
analysis, we acquired patient country of origin data for genomes 
from our Portuguese and Dutch collections, which led to a changed 
country of origin for 13 genomes in this dataset. To restrict the 
number of possible demes of low/single sample size, we collapsed 
countries into eight different geographic categories: Iberia (Portugal, 
Spain, and Cape Verde), North Europe (United Kingdom, Russia, 
Bosnia, Netherlands, and Germany), Peru, Atlantic South America 
(Venezuela, Brazil, Aruba, and Suriname), Congo/Angola, Malawi/
Mozambique, Uganda, and South Africa. The prior population size 
was set to 10,000. Other than this, the analysis was run with the 
same parameters as for the full dataset DTA. The rationale for placing 
Cape Verde in the Iberia category is that Cape Verde was uninhabited 
before Portuguese settlement in the 15th century.
As a complement to DTA, we used the BEAST2 module BASTA 
v2.3.1 (8) for phylogeographic inferences. We specified a migration 
model with the same five demes as above. The initial values for deme 
transition rate were set to 1.0 × 10−3 and the subpopulation to 6000, 
and these numbers correspond to the median outputs from DTA. 
The rate matrix and population size priors were given log-normal 
prior distributions with M = −10 and S = 2.0 and M = 9.0 and S = 
0.6, respectively. Since it was not possible to place deme restrictions 
on internal nodes in BASTA, we artificially introduced an isolate with 
a branch length of 1.0 × 10−10 from the root, and the location of this 
isolate was set to correspond to each of the five demes in different 
runs. The results of these five runs were subsequently evaluated 
jointly. We ran each chain for 1,000,000 generations with storing set 
to every 1000th iteration. We disabled all scaling operators except 
the rate scaler, which was given a scale factor of 0.8 and a weight of 
1.0, and the population size scaler, which was given a weight of 3 and a 
scale factor of 0.8, and degrees of freedom was set to 1 (subpopulation 
sizes effectively set to equal). Since we knew that the MRCA of all iso-
lates existed roughly around the year 1100 CE, before European colo-
nization of the Americas, we discarded all trees with a root inferred to be 
from North or South America. The parameter logs were inspected in 
the same way as described for DTA, and an MCC tree was made using 
TreeAnnotator v.2.4.5, with burn in set to 20% and node heights set to 
median. All BEAST and BEAST2 runs were run locally or on the Cyber-
infrastructure for phylogenetic research (CIPRES) science gateway (58).
Migration matrices (10) were constructed to visualize the overall 
patterns of migration inferred by the two methods. Both methods 
inferred Europe to have played a pivotal role in sourcing the rest of 
the world with TB (fig. S5).
To study migration over time, conceptually mirroring the method-
ology used in (10), we wrote an in-house script (available at https://
github.com/admiralenola/globall4scripts) to read the MCC tree from 
the BASTA runs using the ETE toolkit (59) and traversed the time 
tree in a sliding window fashion, for each year writing out the number 
of branches corresponding to the five different demes. In our analy-
ses, migration events were set to occur on nodes but, in reality, 
could have occurred at any point along the branch downstream of 
this node. This introduces a slight bias toward inflated ages of mi-
gration events, which is most pronounced for very early migration 
events but negligible for later migrations due to extensive branching.
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